Krishna Institute of Medical Sciences Limited (BOM:543308)
535.30
-6.90 (-1.27%)
At close: Feb 21, 2025
BOM:543308 Statistics
Total Valuation
BOM:543308 has a market cap or net worth of INR 214.25 billion. The enterprise value is 233.98 billion.
Market Cap | 214.25B |
Enterprise Value | 233.98B |
Important Dates
The last earnings date was Friday, January 31, 2025.
Earnings Date | Jan 31, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.13% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 207.70M |
Valuation Ratios
The trailing PE ratio is 61.54.
PE Ratio | 61.54 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 13.76 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 67.21 |
EV / Sales | 8.15 |
EV / EBITDA | 32.08 |
EV / EBIT | 40.83 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.78 |
Debt / EBITDA | 2.44 |
Debt / FCF | n/a |
Interest Coverage | 7.23 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 10.08% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 5.73M |
Profits Per Employee | 694,488 |
Employee Count | 5,013 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.27% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +19.27% |
50-Day Moving Average | 606.47 |
200-Day Moving Average | 516.25 |
Relative Strength Index (RSI) | 28.91 |
Average Volume (20 Days) | 16,348 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543308 had revenue of INR 28.72 billion and earned 3.48 billion in profits. Earnings per share was 8.71.
Revenue | 28.72B |
Gross Profit | 17.41B |
Operating Income | 5.73B |
Pretax Income | 5.24B |
Net Income | 3.48B |
EBITDA | 7.18B |
EBIT | 5.73B |
Earnings Per Share (EPS) | 8.71 |
Balance Sheet
The company has 902.00 million in cash and 17.82 billion in debt, giving a net cash position of -16.92 billion.
Cash & Cash Equivalents | 902.00M |
Total Debt | 17.82B |
Net Cash | -16.92B |
Net Cash Per Share | n/a |
Equity (Book Value) | 22.83B |
Book Value Per Share | n/a |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 60.61%, with operating and profit margins of 19.96% and 12.12%.
Gross Margin | 60.61% |
Operating Margin | 19.96% |
Pretax Margin | 18.25% |
Profit Margin | 12.12% |
EBITDA Margin | 25.01% |
EBIT Margin | 19.96% |
FCF Margin | n/a |
Dividends & Yields
BOM:543308 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | 0.13% |
Shareholder Yield | 0.13% |
Earnings Yield | 1.62% |
FCF Yield | n/a |
Stock Splits
The last stock split was on September 13, 2024. It was a forward split with a ratio of 5.
Last Split Date | Sep 13, 2024 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |